Practices and complications of vascular closure devices and manual compression in patients undergoing elective transfemoral coronary procedures

American Journal of Cardiology

Volumn 110, Issue 2, 2012, Pages 177-182

  Smilowitz, Nathaniel R ^a   Kirtane, Ajay J ^a   Guiry, Michael ^a   Gray, William A ^a   Dolcimascolo, Pilar ^a   Querijero, Michael ^a   Echeverry, Claudia ^a   Kalcheva, Nellie ^a   Flores, Braulio ^a   Singh, Varinder P ^a   Rabbani, Leroy ^a   Kodali, Susheel ^a   Collins, Michael B ^a   Leon, Martin B ^a   Moses, Jeffrey W ^a   Weisz, Giora ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; ANGIOCARDIOGRAPHY; APPLICATION SITE INFECTION; ARTERIOVENOUS FISTULA; ARTERY OCCLUSION; ARTERY PERFORATION; BLOOD CLOT LYSIS; BLOOD TRANSFUSION; CASE CONTROL STUDY; CLINICAL PRACTICE; COMPRESSION; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; FALSE ANEURYSM; FEMALE; GROIN HEMATOMA; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MANUAL COMPRESSION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROPERITONEAL HEMORRHAGE; RETROSPECTIVE STUDY; SENESCENCE; VASCULAR ACCESS; VASCULAR ACCESS DEVICE; VASCULAR CLOSURE DEVICE;

AGED; ANGIOPLASTY, BALLOON, CORONARY; BLOOD TRANSFUSION; CASE-CONTROL STUDIES; CATHETER-RELATED INFECTIONS; CORONARY ANGIOGRAPHY; FEMALE; FEMORAL ARTERY; HEMOGLOBINS; HEMOSTATIC TECHNIQUES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VASCULAR DISEASES;

EID: 84862762441     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.02.065     Document Type: Conference Paper

References (30)

1. S.R. Ward, P. Casale, R. Raymond, W.G. Kussmaul III, C. Simpfendorfer Efficacy and safety of a hemostatic puncture closure device with early ambulation after coronary angiography Angio-Seal investigators Am J Cardiol 81 1998 569 572
2. R.J. Applegate, M.T. Sacrinty, M.A. Kutcher, F.R. Kahl, S.K. Gandhi, R.M. Santos, W.C. Little Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998-2007 JACC Cardiovasc Interv 1 2008 317 326
3. B. Ahmed, W.D. Piper, D. Malenka, P. VerLee, J. Robb, T. Ryan, M. Herne, W. Phillips, H.L. Dauerman Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry Circ Cardiovasc Interv 2 2009 423 429
4. M. Koreny, E. Riedmüller, M. Nikfardjam, P. Siostrzonek, M. Müllner Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis JAMA 291 2004 350 357
5. E. Nikolsky, R. Mehran, A. Halkin, E.D. Aymong, G.S. Mintz, Z. Lasic, M. Negoita, M. Fahy, S. Krieger, I. Moussa, J.W. Moses, G.W. Stone, M.B. Leon, S.J. Pocock, G. Dangas Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis J Am Coll Cardiol 44 2004 1200 1209
6. N. Arora, M.E. Matheny, C. Sepke, F.S. Resnic A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices Am Heart J 153 2007 606 611
7. E. Stegemann, R. Hoffmann, S. Marso, B. Stegemann, N. Marx, T. Lauer The frequency of vascular complications associated with the use of vascular closure devices varies by indication for cardiac catheterization Clin Res Cardiol 100 2011 789 795
8. J.H. Deuling, R.P. Vermeulen, R.A. Anthonio, A.F. van den Heuvel, T. Jaarsma, G. Jessurun, B.J. de Smet, E.S. Tan, F. Zijlstra Closure of the femoral artery after cardiac catheterization: a comparison of Angio-Seal, StarClose, and manual compression Catheter Cardiovasc Interv 71 2008 518 523
9. A.K. Rao, C. Pratt, A. Berke, A. Jaffe, I. Ockene, T.L. Schreiber, W.R. Bell, G. Knatterud, T.L. Robertson, M.L. Terrin Thrombolysis in Myocardial Infarction (TIMI) trial - phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase J Am Coll Cardiol 11 1988 1 11
10. L. Yatskar, F. Selzer, F. Feit, H.A. Cohen, A.K. Jacobs, D.O. Williams, J. Slater Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: data from the National Heart, Lung, and Blood Institute Dynamic Registry Catheter Cardiovasc Interv 69 2007 961 966
11. N.A. Omoigui, R.M. Califf, K. Pieper, G. Keeler, M.A. O'Hanesian, L.G. Berdan, D.B. Mark, J.D. Talley, E.J. Topol Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I) J Am Coll Cardiol 26 1995 922 930
12. G. Ndrepepa, P.B. Berger, J. Mehilli, M. Seyfarth, F.J. Neumann, A. Schömig, A. Kastrati Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point J Am Coll Cardiol 51 2008 690 697
13. F.S. Resnic, G.J. Blake, L. Ohno-Machado, A.P. Selwyn, J.J. Popma, C. Rogers Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors Am J Cardiol 88 2001 493 496
14. D.R. Tavris, B.A. Gallauresi, B. Lin, S.E. Rich, R.E. Shaw, W.S. Weintraub, R.G. Brindis, K. Hewitt Risk of local adverse events following cardiac catheterization by hemostasis device use and gender J Invasive Cardiol 16 2004 459 464
15. S.P. Marso, A.P. Amin, J.A. House, K.F. Kennedy, J.A. Spertus, S.V. Rao, D.J. Cohen, J.C. Messenger, J.S. Rumsfeld National Cardiovascular Data Registry Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention JAMA 303 2010 2156 2164
16. M. Brueck, D. Bandorski, K. Rauber, A. Boening Percutaneous transluminal dilatation of inadvertent partial or complete occlusion of the femoral artery caused by Angio-Seal deployment for puncture site closure after cardiac catheterization J Invasive Cardiol 22 2010 353 357
17. R.J. Applegate Unintended consequences of femoral artery closure devices J Invasive Cardiol 22 2010 358 359
18. R.J. Applegate, M.T. Sacrinty, M.A. Kutcher, T.T. Baki, S.K. Gandhi, R.M. Santos, W.C. Little Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention 1998-2003 Catheter Cardiovasc Interv 67 2006 556 562
19. J.E. Exaire, H.L. Dauerman, E.J. Topol, J.C. Blankenship, K. Wolski, R.E. Raymond, E.A. Cohen, D.J. Moliterno TARGET Investigators Triple antiplatelet therapy does not increase femoral access bleeding with vascular closure devices Am Heart J 147 2004 31 34
20. C. Tron, R. Koning, H. Eltchaninoff, R. Douillet, S. Chassaing, C. Sanchez-Giron, A. Cribier A randomized comparison of a percutaneous suture device versus manual compression for femoral artery hemostasis after PTCA J Interv Cardiol 16 2003 217 221
21. F.A. Cura, S.R. Kapadia, P.L. L'Allier, J.P. Schneider, M.S. Kreindel, M.J. Silver, J.S. Yadav, C.C. Simpfendorfer, R.R. Raymond, E.M. Tuzcu, I. Franco, P.L. Whitlow, E.J. Topol, S.G. Ellis Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade Am J Cardiol 86 2000 780 782 A9
22. F. Biancari, V. D'Andrea, C. Di Marco, G. Savino, V. Tiozzo, A. Catania Meta-analysis of randomized trials on the efficacy of vascular closure devices after diagnostic angiography and angioplasty Am Heart J 159 2010 518 531
23. G. Dangas, R. Mehran, S. Kokolis, D. Feldman, L.F. Satler, A.D. Pichard, K.M. Kent, A.J. Lansky, G.W. Stone, M.B. Leon Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices J Am Coll Cardiol 38 2001 638 641
24. H. Eggebrecht, M. Haude, U. Woertgen, A. Schmermund, C. von Birgelen, C. Naber, D. Baumgart, C. Kaiser, O. Oldenburg, T. Bartel, K. Kroeger, R. Erbel Systematic use of a collagen-based vascular closure device immediately after cardiac catheterization procedures in 1,317 consecutive patients Catheter Cardiovasc Interv 57 2002 486 495
25. W.D. Piper, D.J. Malenka, T.J. Ryan Jr, S.J. Shubrooks Jr, G.T. O'Connor, J.F. Robb, K.L. Farrell, M.S. Corliss, M.J. Hearne, M.A. Kellett Jr, M.W. Watkins, W.A. Bradley, B.D. Hettleman, T.M. Silver, P.D. McGrath, J.R. O'Mears, D.E. Wennberg Northern New England Cardiovascular Disease Study Group Predicting vascular complications in percutaneous coronary interventions Am Heart J 145 2003 1022 1029
26. H.M. Farouque, J.A. Tremmel, F. Raissi Shabari, M. Aggarwal, W.F. Fearon, M.K. Ng, M. Rezaee, A.C. Yeung, D.P. Lee Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices J Am Coll Cardiol 45 2005 363 368
27. S. Bangalore, N. Arora, F.S. Resnic Vascular closure device failure: frequency and implications: a propensity-matched analysis Circ Cardiovasc Interv 2 2009 549 556
28. Y. Kanei, T. Kwan, N.C. Nakra, M. Liou, Y. Huang, L.L. Vales, J.T. Fox, J.P. Chen, S. Saito Transradial cardiac catheterization: a review of access site complications Catheter Cardiovasc Interv 78 2011 840 846
29. A.J. Chase, E.B. Fretz, W.P. Warburton, W.P. Klinke, R.G. Carere, D. Pi, B. Berry, J.D. Hilton Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg) Heart 94 2008 1019 1025
30. S.S. Jolly, S. Yusuf, J. Cairns, K. Niemelä, D. Xavier, P. Widimsky, A. Budaj, M. Niemelä, V. Valentin, B.S. Lewis, A. Avezum, P.G. Steg, S.V. Rao, P. Gao, R. Afzal, C.D. Joyner, S. Chrolavicius, S.R. Mehta RIVAL Trial Group Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial Lancet 377 2011 1409 1420